Rani Therapeutics Holdings
RANI · NASDAQ
$0.6528+$0.0025 (+0.38%)TodayMarket closed ·
Prev close $0.6503
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 11.4% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.051 | -$0.04 | +21.6% |
| Q1 FY26 | -$0.0459 | -$0.04 | +12.9% |
| Q4 FY25 | -$0.068 | -$0.07 | −2.9% |
| Q3 FY25 | -$0.1258 | -$0.12 | +4.6% |
| Q2 FY25 | -$0.1989 | -$0.18 | +9.5% |
| Q1 FY25 | -$0.2074 | -$0.22 | −6.1% |
| Q4 FY24 | -$0.2516 | -$0.27 | −7.3% |
| Q3 FY24 | -$0.2623 | -$0.24 | +8.5% |
Earnings calls
- RANI - Earnings call Q4 2025
- RANI - Earnings call Q4 2024
- UBS Global Healthcare Conference 2024
- Special Call - Rani Therapeutics Holdings, Inc.
- RANI - Earnings call Q4 2023
- Special Call - Rani Therapeutics Holdings, Inc.
- Earnings call Q4 2022
- Special Call - Rani Therapeutics Holdings, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.